1. Home
  2. ICU vs SCNX Comparison

ICU vs SCNX Comparison

Compare ICU & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICU
  • SCNX
  • Stock Information
  • Founded
  • ICU 2018
  • SCNX 2010
  • Country
  • ICU United States
  • SCNX United States
  • Employees
  • ICU N/A
  • SCNX N/A
  • Industry
  • ICU Biotechnology: Pharmaceutical Preparations
  • SCNX Other Pharmaceuticals
  • Sector
  • ICU Health Care
  • SCNX Health Care
  • Exchange
  • ICU Nasdaq
  • SCNX Nasdaq
  • Market Cap
  • ICU 25.6M
  • SCNX 21.2M
  • IPO Year
  • ICU N/A
  • SCNX 2020
  • Fundamental
  • Price
  • ICU $0.87
  • SCNX $0.94
  • Analyst Decision
  • ICU
  • SCNX
  • Analyst Count
  • ICU 0
  • SCNX 0
  • Target Price
  • ICU N/A
  • SCNX N/A
  • AVG Volume (30 Days)
  • ICU 1.1M
  • SCNX 298.5K
  • Earning Date
  • ICU 11-12-2025
  • SCNX 11-05-2025
  • Dividend Yield
  • ICU N/A
  • SCNX N/A
  • EPS Growth
  • ICU N/A
  • SCNX N/A
  • EPS
  • ICU N/A
  • SCNX N/A
  • Revenue
  • ICU $766,000.00
  • SCNX $128,202.00
  • Revenue This Year
  • ICU $894.81
  • SCNX N/A
  • Revenue Next Year
  • ICU $71.78
  • SCNX N/A
  • P/E Ratio
  • ICU N/A
  • SCNX N/A
  • Revenue Growth
  • ICU N/A
  • SCNX N/A
  • 52 Week Low
  • ICU $0.31
  • SCNX $0.69
  • 52 Week High
  • ICU $5.34
  • SCNX $9.55
  • Technical
  • Relative Strength Index (RSI)
  • ICU 54.67
  • SCNX 33.59
  • Support Level
  • ICU $0.83
  • SCNX $0.83
  • Resistance Level
  • ICU $0.91
  • SCNX $0.91
  • Average True Range (ATR)
  • ICU 0.07
  • SCNX 0.06
  • MACD
  • ICU -0.00
  • SCNX 0.01
  • Stochastic Oscillator
  • ICU 54.45
  • SCNX 43.05

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About SCNX Scienture Holdings Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Share on Social Networks: